XML 55 R45.htm IDEA: XBRL DOCUMENT v3.22.2
Share-Based Compensation - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of award outstanding   1,888,622   1,888,622   2,501,419
Performance Shares            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share Based Compensation Arrangement By Share Based Payment Award Unrecognized Compensation Costs   $ 0   $ 0    
Allocated Share-based Compensation Expense       $ 1,300    
Number of award outstanding   510,742   510,742    
Biostage Amended and Restated Equity Incentive Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period       4 years    
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period       10 years    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 3,000,000          
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 5,098,000          
Share Price   $ 4.65   $ 4.65    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value   $ 5,000   $ 5,000    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value   $ 2,400   $ 2,400    
Shares available for issuance   2,604,979   2,604,979    
Unrecognized compensation expense   $ 1,400   $ 1,400    
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition       1 year 7 days    
Biostage2013 Equity Incentive Plan [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Allocated Share-based Compensation Expense   $ 277 $ 131 $ 512 $ 261  
Expected dividend yield       0.00% 0.00%